Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Warnock

Showing results (341-350 of 371) with videos related to

Pageof 38
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|April 20, 2016
Association of Reduced eGFR and Albuminuria with Serious Fall Injuries among Older AdultsC Barrett Bowling, Samantha G Bromfield, Lisandro D Colantonio, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 19, 2006
Fabry disease: guidelines for the evaluation and management of multi-organ system involvementChristine M Eng, Dominique P Germain, Maryam Banikazemi, et al.
Molecular Imaging and Biology|January 18, 2015
Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human StudyF Bretin, M A Bahri, C Bernard, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 4, 2010
Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry RegistryChristoph Wanner, João P Oliveira, Alberto Ortiz, et al.
Journal of the American Society of Nephrology : JASN|October 18, 2017
Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac SurgeryMadhav Swaminathan, Mark Stafford-Smith, Glenn M Chertow, et al.
Journal of Medical Genetics|March 22, 2015
Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry diseaseDominique P Germain, Joel Charrow, Robert J Desnick, et al.
Kidney International|August 5, 2019
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney diseasePeter Rossing, Geoffrey A Block, Melanie P Chin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 24, 2014
Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometryChristiane Auray-Blais, Catherine-Marie Blais, Uma Ramaswami, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 2, 2011
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiationDavid G Warnock, Alberto Ortiz, Michael Mauer, et al.
Molecular Genetics and Metabolism|December 3, 2009
A validated disease severity scoring system for Fabry diseaseEdward H Giannini, Atul B Mehta, Max J Hilz, et al.
Pageof 38

Showing results (341-350 of 371) with videos related to

Sort By:
Pageof 38
Clinical Journal of the American Society of Nephrology : CJASN|April 20, 2016
Association of Reduced eGFR and Albuminuria with Serious Fall Injuries among Older AdultsC Barrett Bowling, Samantha G Bromfield, Lisandro D Colantonio, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 19, 2006
Fabry disease: guidelines for the evaluation and management of multi-organ system involvementChristine M Eng, Dominique P Germain, Maryam Banikazemi, et al.
Molecular Imaging and Biology|January 18, 2015
Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human StudyF Bretin, M A Bahri, C Bernard, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 4, 2010
Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry RegistryChristoph Wanner, João P Oliveira, Alberto Ortiz, et al.
Journal of the American Society of Nephrology : JASN|October 18, 2017
Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac SurgeryMadhav Swaminathan, Mark Stafford-Smith, Glenn M Chertow, et al.
Journal of Medical Genetics|March 22, 2015
Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry diseaseDominique P Germain, Joel Charrow, Robert J Desnick, et al.
Kidney International|August 5, 2019
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney diseasePeter Rossing, Geoffrey A Block, Melanie P Chin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 24, 2014
Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometryChristiane Auray-Blais, Catherine-Marie Blais, Uma Ramaswami, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 2, 2011
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiationDavid G Warnock, Alberto Ortiz, Michael Mauer, et al.
Molecular Genetics and Metabolism|December 3, 2009
A validated disease severity scoring system for Fabry diseaseEdward H Giannini, Atul B Mehta, Max J Hilz, et al.
Pageof 38